Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 13, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026 at 10:30 a.m. PT (1:30 p.m. ET).
波士頓，2026年1月13日/PRNewswire/ -- Ginkgo Bioworks（紐約證券交易所代碼：DNA）今天宣佈，聯合創始人兼首席執行官Jason Kelly將於2026年1月15日（星期四）太平洋時間上午10:30（東部時間下午1:30）在第44屆J.P. Morgan醫療保健會議上發表演講。
Further details, including slides, will be posted on the company's investor relations website at .
更多詳細信息，包括幻燈片，將發佈在公司投資者關係網站上。
About Ginkgo Bioworks
關於Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. Ginkgo R&D Solutions delivers customizable R&D packages—such as protein engineering, nucleic acid design, and cell-free systems—giving partners a comprehensive way to accelerate innovation across therapeutics, diagnostics, & manufacturing. Ginkgo Automation sells modular, integrated laboratory automation so scientists can spend their days planning and analyzing experiments rather than pipetting in the lab. Ginkgo Datapoints uses Ginkgo's in-house automation to generate the large lab data sets to power your AI models. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
Ginkgo Bioworks致力於打造讓每個人都能更輕鬆地設計生物學的工具。Ginkgo R&D Solutions提供可定製的研發包——如蛋白質工程、核酸設計和無細胞系統——爲合作伙伴提供了一種全面的方式來加速治療、診斷和製造領域的創新。Ginkgo Automation銷售模塊化、集成化的實驗室自動化設備，使科學家可以花更多時間規劃和分析實驗，而不是在實驗室裏進行移液操作。Ginkgo Datapoints利用Ginkgo內部的自動化生成大型實驗室數據集，爲您的AI模型提供動力。Ginkgo Biosecurity正在構建和部署下一代基礎設施和技術，全球領導者需要這些技術和設施來預測、檢測和應對各種生物威脅。欲了解更多信息，請訪問ginkgobioworks.com和ginkgobiosecurity.com，閱讀我們的博客，或關注我們的社交媒體渠道，例如X（@Ginkgo和@Ginkgo_Biosec）、Instagram（@GinkgoBioworks）、Threads（@GinkgoBioworks）或LinkedIn。
Ginkgo Bioworks Contacts:
Ginkgo Bioworks 聯繫方式：
INVESTOR CONTACT:
[email protected]
投資者聯繫：
[email protected]
MEDIA CONTACT:
[email protected]
媒體聯繫：
[email protected]
SOURCE Ginkgo Bioworks
來源：Ginkgo Bioworks
21%
21%
譯文內容由第三人軟體翻譯。
